The purpose of this clinical study is to gather post-market clinical evidence on the use of
      the Biodesign® Dural and Duraplasty Grafts when used as a dura substitute of the dura mater.

Post-market Assessment of Biodesign Dural Repair Grafts

Cerebrospinal Fluid Leak

Biodesign Dural or Duraplasty Repair Grafts

Post-market Clinical Data Collection Plan for the Biodesign® Dural and Duraplasty Grafts

Clinically relevant CSF leakage is when it requires treatment (e.g., lumbar drain or surgical repair) or leads to an infection of the central nervous system (e.g., meningitis).

Post-market Assessment of Biodesign Dural Repair Grafts

About this trial

Study ID

Status

Type

Placebo

Accepting

Not accepting

Trial Timing

What is this trial about?

What are the participation requirements?